Saliva SARS-CoV-2 Detection Bypassing RNA Isolation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The current diagnostic testing for SARS-CoV-2 using nasopharyngeal swabs is inefficient, uncomfortable for patients, and resource-intensive, with RNA isolation/purification being a significant bottleneck, limiting the ability for widespread and frequent testing needed to control the COVID-19 pandemic.
Innovation Solution
A method for detecting SARS-CoV-2 from saliva samples that bypasses RNA isolation/purification, involving heating the samples with buffering agents and non-ionic detergents, followed by PCR amplification, allowing for direct detection without the need for extraction and purification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If nasopharyngeal swabs with viral transport media are used for SARS-CoV-2 detection, then diagnostic accuracy is improved, but sample collection complexity and healthcare worker safety risks increase
Solution Approach 1:
The patent extracts the virus detection function from the complex nasopharyngeal swabbing process by using saliva as a surrogate sample type. This allows detection of SARS-CoV-2 through a simpler, less invasive collection method while maintaining diagnostic capability through targeted PCR amplification of viral genetic material in the saliva sample
Solution Approach 2:
The patent enables self-service sample collection by allowing patients to collect their own saliva samples without requiring healthcare workers. This eliminates the need for trained personnel to perform invasive swabbing procedures, reducing both complexity and safety risks while patients can provide the sample themselves through simple spitting or swishing motions
2Measurement precision
If RNA isolation and purification are performed on saliva samples, then detection sensitivity is improved, but processing time and operational complexity increase
Solution Approach 1:
The patent extracts only the essential viral genetic material detection function from the complete RNA isolation workflow. By using saliva as the sample matrix and implementing a simplified nucleic acid extraction protocol that skips complex purification steps, the method achieves sufficient detection sensitivity for clinical diagnostics while dramatically reducing processing time and operational complexity
Solution Approach 2:
The patent applies partial action by performing only the critical extraction steps needed to release viral RNA from saliva without completing the full isolation and purification sequence. This partial processing approach provides adequate sensitivity for detection purposes while eliminating time-consuming steps, achieving the optimal balance between detection quality and throughput efficiency
3Measurement precision
If standard PCR protocols are used on saliva samples, then viral detection accuracy is maintained, but sample preparation complexity increases
Solution Approach 1:
The patent modifies the sample matrix parameter by using saliva instead of nasopharyngeal swab eluate, and adjusts the extraction conditions parameter by optimizing buffer compositions and incubation temperatures specifically for saliva. These parameter changes enable the use of simplified preparation protocols while maintaining the accuracy needed for reliable viral detection through standard PCR amplification
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables convenient, scalable, and cost-effective molecular diagnostic testing for thousands of individuals, improving the efficiency and accessibility of SARS-CoV-2 detection by using saliva samples, which can be collected easily and are more reflective of transmission potential.
Implementation Method 1
heating the samples with buffering agents and non-ionic detergents
Implementation Method 2
contacting the biological sample with one or more buffering agents and one or more non-ionic detergent to form a test sample
Implementation Method 3
combining the saliva sample with TBE at about a 1:1 ratio prior to heating the saliva sample
Data Source
AI summary
A saliva-based testing method that bypasses the need for RNA isolation/purification is described herein. In experiments with inactivated SARS-CoV-2 virus spiked into saliva, this method has a limit of detection of 500-1000 viral particles per mL, rivalling the standard NP swab method. Initial studies showed excellent performance with 100 clinical samples. This saliva-based process is operationally simple, utilizes readily available materials, and can be easily implemented by existing testing sites thus allowing for high-throughput, rapid, and repeat testing of large populations.